Compare KURA & AMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KURA | AMC |
|---|---|---|
| Founded | 2014 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 830.1M | 825.8M |
| IPO Year | N/A | 2013 |
| Metric | KURA | AMC |
|---|---|---|
| Price | $8.35 | $1.24 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 5 |
| Target Price | ★ $26.88 | $2.58 |
| AVG Volume (30 Days) | 1.4M | ★ 47.0M |
| Earning Date | 02-26-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $104,029,000.00 | ★ $4,867,000,000.00 |
| Revenue This Year | $88.72 | $5.34 |
| Revenue Next Year | $68.75 | $10.24 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.74 |
| 52 Week Low | $5.41 | $1.21 |
| 52 Week High | $12.49 | $4.08 |
| Indicator | KURA | AMC |
|---|---|---|
| Relative Strength Index (RSI) | 44.59 | 39.38 |
| Support Level | $7.50 | $1.21 |
| Resistance Level | $8.08 | $1.51 |
| Average True Range (ATR) | 0.34 | 0.10 |
| MACD | 0.07 | -0.00 |
| Stochastic Oscillator | 68.99 | 30.06 |
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.